What Do Drug Monopolies Cost Consumers in Developing Countries?
11 Pages Posted: 24 Dec 2011
Date Written: December 1, 2011
Abstract
This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups
JEL Classification: D4, F13, L1, L65, O34
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Intellectual Property Rights and North-South Trade
By Judith C. Chin and Gene M. Grossman
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Reaping What You Sow: An Empirical Analysis of International Patent Harmonization
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Patents, Appropriate Technology, and North-South Trade
By Ishac Diwan and Dani Rodrik
-
The North's Intellectual Property Rights Standard for the South?
By Edwin L.-c. Lai and Larry D. Qiu